# Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

> **NCT05171998** · — · COMPLETED · sponsor: **Cwm Taf University Health Board (NHS)** · enrollment: 30 (actual)

## Conditions studied

- SARS-CoV2 Infection Common Pathogens
- Diabetes Mellitus, Type 1

## Interventions

- **PROCEDURE:** venous blood sample

## Key facts

- **NCT ID:** NCT05171998
- **Lead sponsor:** Cwm Taf University Health Board (NHS)
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171998, "Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05171998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*